Mn Services Vermogensbeheer B.V. Increases Holdings in Waters Corporation $WAT

Key Points

• Mn Services Vermogensbeheer B.V. increased its stake in Waters Corporation by 7.0% in Q2, owning a total of 22,933 shares valued at approximately $8 million.
• Other institutional investors also boosted their positions in Waters, with Swedbank AB leading the increase at 25.8%, bringing its holdings to over $14 million.
• Waters Corporation reported Q2 earnings of $2.95 per share, surpassing expectations, and projected Q3 2025 guidance between $3.150 and $3.250 EPS.

Mn Services Vermogensbeheer B.V. increased its position in Waters Corporation (NYSE:WAT - Free Report) by 7.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 22,933 shares of the medical instruments supplier's stock after acquiring an additional 1,500 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Waters were worth $8,005,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Swedbank AB boosted its holdings in Waters by 25.8% in the 2nd quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier's stock valued at $14,145,000 after purchasing an additional 8,305 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Waters by 2.8% in the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 6,728 shares of the medical instruments supplier's stock worth $2,348,000 after buying an additional 185 shares in the last quarter. Sivia Capital Partners LLC bought a new stake in Waters during the second quarter valued at $232,000. Gateway Investment Advisers LLC grew its position in Waters by 3.0% during the second quarter. Gateway Investment Advisers LLC now owns 2,085 shares of the medical instruments supplier's stock worth $728,000 after buying an additional 60 shares in the last quarter. Finally, Czech National Bank increased its stake in Waters by 6.7% in the 2nd quarter. Czech National Bank now owns 14,546 shares of the medical instruments supplier's stock worth $5,077,000 after acquiring an additional 909 shares during the last quarter. Hedge funds and other institutional investors own 94.01% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Bank of America boosted their price objective on Waters from $370.00 to $375.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. UBS Group reissued a "neutral" rating on shares of Waters in a report on Tuesday, July 15th. Jefferies Financial Group set a $385.00 target price on shares of Waters and gave the stock a "buy" rating in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the company a "hold" rating in a research report on Tuesday, August 5th. Finally, Scotiabank reiterated a "sector outperform" rating and issued a $465.00 price objective on shares of Waters in a report on Friday, July 11th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, Waters presently has a consensus rating of "Hold" and a consensus target price of $378.73.

Waters Stock Up 0.3%

Shares of WAT traded up $1.03 on Monday, reaching $301.90. The stock had a trading volume of 453,320 shares, compared to its average volume of 623,224. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56. The firm has a market capitalization of $17.97 billion, a price-to-earnings ratio of 27.25, a price-to-earnings-growth ratio of 2.81 and a beta of 1.07. The company has a 50-day simple moving average of $294.95 and a 200-day simple moving average of $330.17.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The business had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. During the same quarter in the prior year, the company earned $2.63 earnings per share. The firm's quarterly revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Sell-side analysts predict that Waters Corporation will post 12.86 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.